49,267
edits
Difference between revisions of "MOC31"
Jump to navigation
Jump to search
no edit summary
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''MOC31''' is an [[immunostain]]. | '''MOC31''' is an [[immunostain]]. The antibody is directed against the epithelial cell adhesion molecule (Ep-CAM, TACSTD1).<ref name=pmid19391212/> | ||
==Negative== | ==Negative== | ||
*[[Hepatocellular carcinoma]].<ref name=pmid10937059/> | *[[Hepatocellular carcinoma]].<ref name=pmid10937059>{{Cite journal | last1 = Proca | first1 = DM. | last2 = Niemann | first2 = TH. | last3 = Porcell | first3 = AI. | last4 = DeYoung | first4 = BR. | title = MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers. | journal = Appl Immunohistochem Mol Morphol | volume = 8 | issue = 2 | pages = 120-5 | month = Jun | year = 2000 | doi = | PMID = 10937059 }}</ref> | ||
*[[Malignant mesothelioma|Malignant epithelioid mesothelioma]] - usually negative.<ref name=pmid9490276/> | *[[Malignant mesothelioma|Malignant epithelioid mesothelioma]] - usually negative.<ref name=pmid9490276/> | ||
| Line 16: | Line 14: | ||
==See also== | ==See also== | ||
*[[Immunohistochemistry]]. | *[[Immunohistochemistry]]. | ||
*[[Ber-EP4]]. | |||
==References== | ==References== | ||